Meanwhile, blockade of VISTA with neutralising antibody reprogrammed tumour-associated macrophages into a pro-inflammatory and classically tumour-suppressive phenotype and restored CD8 + T cell activation and function in-vitro and in-vivo, both at the primary and lung metastatic site. The gene discussed is VSIR; the disease is neoplasm.